• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Meridian Bioscience Inc

+ Add to Watchlist


14.915 EUR 0.050 0.33%

As of 02:04:13 ET on 08/28/2014.

Snapshot for Meridian Bioscience Inc (MR4)

Open: 14.813 Day's Range: 14.813 - 14.915 Volume: 0
Previous Close: 14.965 52wk Range: 13.774 - 19.905 1-Yr Rtn: -8.86%

Stock Chart for MR4

No chart data available.
  • MR4:GR 14.915
  • 1D
  • 1M
  • 1Y
Interactive MR4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MR4

Current P/E Ratio (ttm) -
Estimated P/E(09/2014) 22.9015
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (09/2014) 0.8600
Est. PEG Ratio 1.6358
Market Cap (M EUR) 619.98
Shares Outstanding (M) 41.57
30 Day Average Volume 3
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 4.01%
Cash Dividend (USD) 0.2000
Dividend Ex-Date 07/31/2014
5 Year Dividend Growth 3.41%
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MR4

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MR4

Meridian Bioscience, Inc. manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products. The Company also offers bio- pharmaceutical enabling technologies. Meridian specializes in gastrointestinal and upper respiratory infections, serology, parasitology, and fungal disease diagnosis, as well as rare reagents and specialty biologicals.

William J MottoChairman/FounderJohn A KraeutlerChief Executive Officer
Marco G CalzavaraPres & Mng Dir:EuropeMelissa A LuekeExec VP/CFO/Secretary
More Company Profile & Key Executives for MR4

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil